OpenAI has announced the broad availability of ChatGPT Health, a feature designed to assist users with health-related inquiries, to all U.S. residents aged 18 and older across its entire range of subscription plans. This rollout closely follows a lawsuit filed by a Florida pastor, who alleged the company provided a dangerously misleading suggestion to forgo medical consultation.
The company initiated pilot testing for this functionality in January, utilizing a specialized hub that enabled users to integrate personal health data from various external services, including Apple Health, Function, and MyFitnessPal.
During the initial testing phase, OpenAI reported an astounding 230 million health-related queries processed weekly. This figure has since climbed significantly, now reaching 300 million queries per week.
Furthermore, users are able to integrate their medical records directly from prominent hospital systems such as Epic and Oracle Health, as well as health platforms including One Medical and Function Health.
While earlier iterations mandated the use of the dedicated health hub for specific health queries, users can now opt to leverage insights from their connected health information within any general chat inquiry. OpenAI revealed that testing indicated 70% of health-related questions were posed outside the specialized hub. This new capability allows users to seamlessly incorporate their personal health data, such as allergies, into broader conversations within the general chat interface.
OpenAI highlighted significant advancements in its models' ability to address health-related inquiries. Notably, its most compact model from the latest release, GPT 5.6-Luna, has demonstrated superior performance compared to GPT 5.5 on the HealthBench evaluation, an open-source benchmark developed internally to assess large language models (LLMs) on health-specific questions. The company also affirmed its commitment to user privacy, stating that no user data is utilized for model training, and it actively collaborates with medical professionals to enhance the accuracy and safety of its health query responses.
Notwithstanding these performance enhancements, OpenAI explicitly states in its terms of service that its offerings are “not intended for use in the diagnosis or treatment of any health condition.” These clauses were referenced by the company in its response to the aforementioned lawsuit. Furthermore, OpenAI informed The New York Times of its ongoing efforts to enhance the safety of health- and medicine-related responses. With this latest deployment, OpenAI underscores the importance for users to verify information independently and to base all medical decisions on professional advice.
Numerous studies have consistently indicated that AI-powered chatbots lack the necessary reliability for providing medical advice. Despite these findings, major technology firms such as Anthropic and Google continue to introduce their own AI-driven health features.
The ChatGPT Health feature is being progressively rolled out this week to logged-in users in the U.S. who subscribe to Free, Go, Plus, and Pro plans, accessible via both web and iOS platforms.
The Editorial Staff at AIChief is a team of professional content writers with extensive experience in AI and marketing. Founded in 2025, AIChief has quickly grown into the largest free AI resource hub in the industry.